Articles related to Geriatrics

Online wellness messaging is reframing nicotine pouches, gum, and patches as cognitive enhancers and dementia prevention tools, despite negative results from the larger MIND trial published in December 2025.

Multiple Alzheimer disease biomarkers showed accelerated age-related changes near age 70 in a Mayo Clinic Study of Aging cohort, identifying potential screening and monitoring windows.

The FDA approved dextromethorphan-bupropion (Auvelity) for agitation associated with dementia due to Alzheimer’s disease, based on phase 3 trial data and a long-term randomized withdrawal study.

Consumer-facing guidance from Verywell Mind highlights how depression in adults over 60 frequently manifests as somatic complaints, cognitive changes, and social withdrawal rather than overt mood symptoms.

Three recent studies examined associations between vitamin D status and outcomes across type 2 diabetes risk, Alzheimer’s biomarkers, and inflammatory bowel disease in exploratory cohorts.

Eleven commonly prescribed medication classes have been associated with new or worsening depression symptoms, with risk varying by dose, duration, and patient population.